NCT05020678 2026-04-20NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell CancersNkarta, Inc.Phase 1 Active not recruiting150 enrolled
NCT06544265 2026-04-14SynKIR-310 for Relapsed/Refractory B-NHLVerismo TherapeuticsPhase 1 Recruiting36 enrolled